Ligand Pharmaceuticals (LGND) Q2 2025 Earnings Call August 07, 2025 08:30 AM ET Company ParticipantsMelanie Herman - Executive Director - IR & FP&ATodd Davis - CEO & DirectorPaul Hadden - SVP - Investments & Business DevelopmentTavo Espinoza - CFOLauren Hay - Vice President - Strategic Planning & Investment AnalyticsConference Call ParticipantsTrevor Allred - Senior Analyst - BiotechnologyDouglas Miehm - Healthcare AnalystMatthew Hewitt - Senior Research AnalystLarry Solow - Partner & Managing director - Eq ...